WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 28-May-2015 (Data received as of 22-May-2015)
Next overall update July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'5801 Infant (under 12 months) mortality rate: 262
GDP / capita (US$): 9'5591 Child (under 5 years) mortality rate: 312

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 252'812  249'866  246'864  243'802  240'676  208'939  178'633  145'494 
Births 4'648  4'691  4'736  4'781  4'821  4'505  4'624  4'867 
Surviving infants 4'534  4'572  4'614  4'654  4'689  4'333  4'373  4'493 
Pop. less than 5 years 23'313  23'979  24'622  25'019  25'074  21'029  21'905  21'664 
Pop. less than 15 years 71'950  72'186  72'329  72'220  71'792  64'060  65'054  59'751 
Female 15-49 years 67'520  66'841  66'144  65'488  64'897  57'514  45'242  34'583 

Number of reported case

(Click for retrospective incidence data for Indonesia)
Diphtheria 775  1'192  806  432  23  2'200  3'674 
Japanese encephalitis
Measles 8'419  15'489  21'893  18'869  3'344  92'105  28'935 
Mumps
Pertussis 2'976  1'941  142  30'014  32'999 
Polio* 35  465  182 
Rubella 2'355  1'020  1'959  1'323 
Rubella (CRS)
Tetanus (neonatal) 69  106  114  147  466  1'427  954 
Tetanus (total)** 225  106  210  147  466  7'784  7'231 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Indonesia)
Vaccine year result method % card seen                                                
BCG 2011  89  DHS   41  89  92  89  97  97  87  94  61 
DTP1 2011  88  DHS   41  88  93  88  93  94  87 
DTP3 2011  72  DHS   41  73  86  73  83  83  77  88 
HepB_BD          79  84  80  80  75  55 
HepB3 2011  42  DHS   41  73  86  73  83  83  65 
Hib3          44  36 
JapEnc         
MCV 2011  80  DHS   41  81  89  84  89  89  73  85 
MCV2          28  93  81  85  85 
PCV1         
PCV3         
Pol3 2011  76  DHS   41  77  87  78  92  93  74  89 
Rota1         
Rota_last         
Rubella1         
TT2plus 2011  45  DHS   41  52  66  70  71  71  81  61 
PAB         
VAD1          85  82  83  75  60 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Indonesia)
BCG 98  99  98  88  81  74  61 
DTP1 98  98  98  97  84  82 
DTP3 85  83  81  81  75  60 
HepB3 85  83  81  83  65 
HepB_BD
Hib3
MCV 84  85  80  78  76  58 
MCV2 79  78  76  74 
PAB 85  85  85  85  82  64 
PCV3
Pol3 86  84  81  82  72  60 
Rota_last

Number of districts in the country 509  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
98 
   
/
|
|
\
Greater or equal to 90% 52
From 80 to 89% 17
From 50 to 79% 25
Less than 50% 4
Proportion of districts
not reporting DTP3 coverage
2
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1 month; Yes
DT 6-7 years; Yes
DTwPHep 2, 3, 4 months; Yes
DTwPHibHepB 2, 3, 4, 18 months; Yes
HepB 0-7 days; Yes
IPV 2, 3, 4 months; No
Measles 9, 24 months; 6-7 years; Yes second dose at 24 months in selected province
OPV 1, 2, 3, 4 months; Yes
TT 15-39 years; Yes CBAW
Td 7-8, 8-9 years; Yes
VitaminA 6-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2019  2010-2014  2010-2014  2010-2014  2010-2014  2007-2011  2007 - 2011 
Nº of districts with microplans that include activities to raise immunization coverage number 179  184  58  497  495  46  464 

System performance

Total Nº districts in country number 509  497  497  497  495  475  464 
Nº districts with DTP3 coverage >=80% number 354  412  392  397  389  382  367 
% of districts with DTP3 coverage >=80% From 0 to 100% 70  83  79  80  79  80  79 
Nº districts with measles (MCV1) coverage >=95% number 199  226  269  198  197  162  148 
% of districts with MCV1 coverage >=95% From 0 to 100% 39  45  54  40  40  34  32 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 64  60    99  83  80  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.